{"denomUnitsSelected":"Participants","description":"Safety associated with both induction alone and with 3 part therapy consisting of induction chemotherapy, surgery and risk-adapted use of chemoradiation will be assessed via the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE v4.03)","reportingStatus":"NOT_POSTED","timeFrame":"90 days after the last dose of study treatment","title":"Toxicity Profile Associated With Both Induction Therapy and Total 3 Part Therapy Consisting of Induction Chemotherapy, Surgery and Risk-adapted Use of Chemoradiation","type":"SECONDARY"}